Jamp-Atorvastatin 40 mg tablets recalled due to risk of latex contamination
In plain language
This recall involves Jamp-Atorvastatin 40 mg tablets sold in Canada. It's being recalled because of possible latex contamination during manufacturing. Do not take the product if you have it. Check lot codes in the official notice.
What to do
- Check if your product matches the affected lot code MHC1403A listed in the official notice.
- Do not take the product.
- Return it to your pharmacy for a replacement and proper disposal.
- Contact Jamp Pharma Corporation if you need more details.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Jamp-Atorvastatin 40 mg tablets
Lot: MHC1403A
Date codes: 2023-09-30
Why this matters
Possible latex contamination
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the date code
Date codes are usually printed near the best-before date or on the packaging seam.
Affected date codes: 2023-09-30
- 3
Check the lot number
Lot numbers identify specific production batches.
Affected lots: MHC1403A
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Possible latex contamination
What should consumers do?
Check if your product matches the affected lot code MHC1403A listed in the official notice. Do not take the product. Return it to your pharmacy for a replacement and proper disposal. Contact Jamp Pharma Corporation if you need more details.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Possible latex contamination
When was this product recalled?
This product was recalled on August 6, 2022.
Is the Jamp-Atorvastatin brand affected by this recall?
Yes, Jamp-Atorvastatin products are affected by this recall. This recall involves Jamp-Atorvastatin 40 mg tablets sold in Canada. It's being recalled because of possible latex contamination during manufacturing. Do not take the product if you have it. Check lot codes in the official notice.